Aidea Pharma: Ainomit Tablets Obtains Drug Registration Certificate in Zanzibar
I'm PortAI, I can summarize articles.
Aidea Pharma recently obtained the Drug Registration Certificate for Ainomi Tablets issued by the Zanzibar Food and Drug Authority. This drug is a compound anti-HIV-1 infection chemical drug developed independently by the company, based on the novel non-nucleoside reverse transcriptase inhibitor Ainovelin Tablets, which includes two nucleoside reverse transcriptase inhibitors: fumarate tenofovir disoproxil and lamivudine
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments